Cragg MS - Search Results

1

Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells.

Cragg MS, Zhang L, French RR, Glennie MJ. Cragg MS, et al. Br J Cancer. 1999 Feb;79(5-6):850-7. doi: 10.1038/sj.bjc.6690136. Br J Cancer. 1999. PMID: 10070880 Free PMC article.

2

The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease.

Zhang L, French RR, Chan HT, O'Keefe TL, Cragg MS, Power MJ, Glennie MJ. Zhang L, et al. Among authors: cragg ms. Ther Immunol. 1995 Aug;2(4):191-202. Ther Immunol. 1995. PMID: 9358611

3

Molecular markers of B-cell lymphoma.

Stevenson GT, Cragg MS. Stevenson GT, et al. Among authors: cragg ms. Semin Cancer Biol. 1999 Apr;9(2):139-47. doi: 10.1006/scbi.1998.0085. Semin Cancer Biol. 1999. PMID: 10202135 Review.

4

The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma.

Illidge TM, Cragg MS, McBride HM, French RR, Glennie MJ. Illidge TM, et al. Among authors: cragg ms. Blood. 1999 Jul 1;94(1):233-43. Blood. 1999. PMID: 10381518

5

Signaling antibodies in cancer therapy.

Cragg MS, French RR, Glennie MJ. Cragg MS, et al. Curr Opin Immunol. 1999 Oct;11(5):541-7. doi: 10.1016/s0952-7915(99)00010-2. Curr Opin Immunol. 1999. PMID: 10508709 Review.

6

Complement mediated cell death is associated with DNA fragmentation.

Cragg MS, Howatt WJ, Bloodworth L, Anderson VA, Morgan BP, Glennie MJ. Cragg MS, et al. Cell Death Differ. 2000 Jan;7(1):48-58. doi: 10.1038/sj.cdd.4400627. Cell Death Differ. 2000. PMID: 10713720

7

Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage.

Illidge TM, Cragg MS, Fringes B, Olive P, Erenpreisa JA. Illidge TM, et al. Among authors: cragg ms. Cell Biol Int. 2000;24(9):621-33. doi: 10.1006/cbir.2000.0557. Cell Biol Int. 2000. PMID: 10964452

8

A new in vivo and in vitro B cell lymphoma model, pi-BCL1.

Illidge T, Honeychurch J, Howatt W, Ross F, Wilkins B, Cragg M. Illidge T, et al. Cancer Biother Radiopharm. 2000 Dec;15(6):571-80. doi: 10.1089/cbr.2000.15.571. Cancer Biother Radiopharm. 2000. PMID: 11190489

9

Radioimmunotherapy in the pi-BCL1 B cell lymphoma model: efficacy depends on more than targeted irradiation alone.

Illidge T, Honeychurch J, Vandersteen A, Cragg M. Illidge T, et al. Cancer Biother Radiopharm. 2000 Dec;15(6):581-91. doi: 10.1089/cbr.2000.15.581. Cancer Biother Radiopharm. 2000. PMID: 11190490

10

The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.

Cragg MS, Chan HT, Fox MD, Tutt A, Smith A, Oscier DG, Hamblin TJ, Glennie MJ. Cragg MS, et al. Blood. 2002 Nov 1;100(9):3068-76. doi: 10.1182/blood.V100.9.3068. Blood. 2002. PMID: 12384401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results